Yasir Y. Elamin

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-5312-909X

发表论文 198 篇 · 总被引 8400 次 · h-index 36

代表论文

• CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2024 · Nature · 被引 169)
• A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve EGFR -Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial) (2024 · Journal of Clinical Oncology · 被引 47)
• The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer (2025 · The Annals of Thoracic Surgery · 被引 21)
• Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature Review (2024 · Journal of Thoracic Oncology · 被引 20)
• Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study (2025 · Journal of Thoracic Oncology · 被引 11)
• Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity (2025 · Nature Communications · 被引 9)